Invention Grant
- Patent Title: Crystalline form of cabazitaxel and process for preparing the same
- Patent Title (中): 卡巴他赛的结晶形式及其制备方法
-
Application No.: US14301740Application Date: 2014-06-11
-
Publication No.: US09309210B2Publication Date: 2016-04-12
- Inventor: Eric Didier , Nicolas Tremaudeux , Lionel Zaske
- Applicant: Aventis Pharma SA
- Applicant Address: FR Antony
- Assignee: AVENTIS PHARMA S.A.
- Current Assignee: AVENTIS PHARMA S.A.
- Current Assignee Address: FR Antony
- Agent Kelly L. Bender
- Priority: EP11306644 20111213
- Main IPC: C07D305/14
- IPC: C07D305/14
Abstract:
The present invention relates to a novel crystalline ethyl acetate solvate form of cabazitaxel or 4α-acetoxy-2α-benzoyloxy-5β,20-epoxy-1β-hydroxy-7β,10β-dimethoxy-9-oxo-11-taxen-13α-yl(2R,3S)-3-tert-butoxycarbonylamino-2-hydroxy-3-phenylpropionate and process for preparing the same.
Public/Granted literature
- US20140343133A1 CRYSTALLINE FORM OF CABAZITAXEL AND PROCESS FOR PREPARING THE SAME Public/Granted day:2014-11-20
Information query
